Circulating biomarkers in renal cell carcinoma
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210951
- Recipient
-
Dana-Farber Cancer Institute, Inc. UEI DPMGH9MG1X67
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,290,500
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Boston, MA 02115, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $1,290,500 Project Grant to Dana-Farber Cancer Institute, Inc. to support research titled "CIRCULATING BIOMARKERS IN RENAL CELL CARCINOMA" under the Military Medical Research and Development program (CFDA 12.420). The four-year award beginning September 1, 2022 will fund research to investigate circulating biomarkers in renal cell carcinoma. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research, including investigating medical solutions applicable to battlefield medicine. Dana-Farber Cancer Institute will leverage the funding to advance biomarker discovery efforts that could enhance early detection and treatment of kidney cancer.
Quick answers
Who received award W81XWH2210951?
W81XWH2210951 was awarded to Dana-Farber Cancer Institute, Inc. by Medical Command (Department of the Army) on September 1, 2022.
How much is award W81XWH2210951 worth?
$1,290,500 has been obligated on W81XWH2210951.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award